Information Provided By: 
Fly News Breaks for October 6, 2015
NUVA
Oct 6, 2015 | 07:55 EDT
As reported previously, Canaccord upgraded NuVasive to Buy from Hold as they believe a current and projected strong U.S. macro environment for the broad spine market offsets tough comps and will continue to provide a solid tailwind. The firm also sees continued margin expansion and integration of its iGA platform strategy. Canaccord raised its price target to $58 from $52 on NuVasive shares.
News For NUVA From the Last 2 Days
There are no results for your query NUVA
